Literature DB >> 34254991

The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease.

Robert Steinbrook1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34254991     DOI: 10.1001/jamainternmed.2021.4622

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

Review 1.  "The Wandering Nerve Linking Heart and Mind" - The Complementary Role of Transcutaneous Vagus Nerve Stimulation in Modulating Neuro-Cardiovascular and Cognitive Performance.

Authors:  Helena Dolphin; Tim Dukelow; Ciaran Finucane; Sean Commins; Paul McElwaine; Sean P Kennelly
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

2.  Expedited regulatory product approval in the time of COVID-19.

Authors:  Gary D Novack
Journal:  Ocul Surf       Date:  2022-05-28       Impact factor: 6.268

Review 3.  The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics.

Authors:  Eric Karran; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2022-02-17       Impact factor: 112.288

4.  Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer's disease.

Authors:  Yunlong Xu; Chenyu Jiang; Junyan Wu; Peidong Liu; Xiaofei Deng; Yadong Zhang; Bo Peng; Yingjie Zhu
Journal:  CNS Neurosci Ther       Date:  2021-12-10       Impact factor: 5.243

Review 5.  The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?

Authors:  Lorena Perrone; Mariarosaria Valente
Journal:  Biomolecules       Date:  2021-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.